USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
03 May 2022 | 02:45 PM GMT

Digital Measures in Clinical Trials: Selection process & Validation

Participants:

Chandana Fitzgerald President, CommunityHLTH
Chandana Fitzgerald
President, CommunityHLTH
Chris Cera CEOArcweb Technologies
Chris Cera
CEOArcweb Technologies
Daniela Deflorio GCP Lead Instructor and Principal ConsultantDadal Consulting
Daniela Deflorio
GCP Lead Instructor and Principal ConsultantDadal Consulting
Erwin De beuckelaer Director InnovationJohnson & Johnson
Erwin De beuckelaer
Director InnovationJohnson & Johnson
OG
Oliver Gibson Director of ResearchOxehealth
OG
Oliver Gibson
Director of ResearchOxehealth
Reginald Swift Founder & CEORubix LS
Reginald Swift
Founder & CEORubix LS
Steve Peretz Healthcare Practice Lead, Digital ProductsAppnovation
Steve Peretz
Healthcare Practice Lead, Digital ProductsAppnovation
Tanja Dowe Managing Director Angelini Ventures
Tanja Dowe
Managing Director Angelini Ventures
Tracy Lahey Strategy & Business Development ManagerAmgen
Tracy Lahey
Strategy & Business Development ManagerAmgen
Vasyl Pyrozhyk Vice PresidentSMBC
Vasyl Pyrozhyk
Vice PresidentSMBC
Vasyl Pyrozhyk Vice President - HealthcareSumitomo Mitsui Banking Corporation
Vasyl Pyrozhyk
Vice President - HealthcareSumitomo Mitsui Banking Corporation

About this Meeting

Are you working on incorporating digital measures into clinical trials? This is for you! 

In the last few years, we have seen an increase in the use of digital measurement technologies to report the outcomes of clinical trials. But there are still a lot of questions to be addressed before this becomes the norm for all the sponsors. Join the HealthXL community in this meeting to discuss the following: 

  • Important factors to consider when selecting the right digital measures to report the outcomes of a clinical trial and how the selection process looks like. 
  • Once you have selected the right digital measurements for your trial, how to compare different tech solutions that can measure the same? How to decide which one is the best choice for a specific trial?  
  • Technical & Clinical validation of digital measures and the tech solutions measuring these: who is responsible for this validation, requirements of the different stakeholders, validation of software vs. hardware, how to deal with software updates/iterations and how to improve the current validation process.  
  • How do the answers to these questions change depending on the phase of the study?